Skip to main content

CVS Health Value Stock - Dividend - Research Selection

Cvs health

ISIN: US1266501006 , WKN: 859034

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


CVS Has Two Hurdles to Clear in Earnings. Medicare Advantage Just Might Be the Lower One.

2026-05-05
CVS Health’s Aetna was the third-largest provider of Medicare Advantage plans in 2025, behind UnitedHealth Group and Humana.

Essential retailer shuts hundreds of stores as protests grow

2026-05-05
Just because a market needs a store does not mean retailers can make money operating in that area. In some cases, there's simply not a large enough population to justify opening or operating a store. In other cases, the economics of the population simply don't work. That's why some markets have ...

CVS Caremark Expands Biosimilar Adoption Through Formulary Updates to Improve Affordability and Access

2026-05-05
CVS Health (NYSE: CVS) today announced updates to its most common commercial template formularies that will expand the use of lower-cost biosimilars across multiple therapeutic categories, including changes effective July 1, 2026, that will prefer interchangeable biosimilars over select reference brands.

Fathom Secures Strategic Investment From CVS Health Ventures to Accelerate Enterprise-Wide Autonomous Coding

2026-05-05
SAN FRANCISCO - Fathom, a leader in autonomous medical coding, has announced a strategic investment from CVS Health Ventures, the venture capital arm of CVS Health. The funding reflects growing demand...

Major health insurers show signs of recovery – but a key test looms

2026-05-05
Insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the second quarter as the real test.

Jim Cramer Says “I Think That CVS Will Give You a Good Quarter”

2026-05-04
CVS Health Corporation (NYSE:CVS) was among the stocks on Jim Cramer’s radar on Mad Money as he discussed the upcoming earnings. Cramer expects a good quarter from the company, as he commented: I might be on a roll here, and I want to press my bet by telling you that I think that CVS will […]

Fathom secures strategic investment from CVS Health Ventures

2026-05-04
Fathom: Fathom: secures strategic investment from CVS Health Ventures to accelerate enterprise-wide autonomous coding...

Berkshire Hathaway meeting, Spirit shuts down, Meta's return to court and more in Morning Squawk

2026-05-04
Here are five key things investors need to know to start the trading day.

Drugmakers petition Supreme Court to restore mifepristone mail-order access

2026-05-03
Investing.com -- Danco Laboratories and GenBioPro have filed emergency applications with the U.S. Supreme Court seeking to reinstate mail-order access to the abortion pill mifepristone, as first reported by Reuters.

Piper Sandler Companies Q1 Earnings Call Highlights

2026-05-02
Piper Sandler Companies (NYSE:PIPR) opened fiscal 2026 with what management called a “strong start to the year,” driven by record first-quarter results in corporate investment banking and advisory, alongside record equity brokerage revenues. Chairman and CEO Chad Abraham said the firm generated fir